Oehlenschläger F, Schwille P, Eigen M
Department of Biochemical Kinetics, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12811-6. doi: 10.1073/pnas.93.23.12811.
Nucleic acid sequence-based amplification (NASBA) has proved to be an ultrasensitive method for HIV-1 diagnosis in plasma even in the primary HIV infection stage. This technique was combined with fluorescence correlation spectroscopy (FCS) which enables online detection of the HIV-1 RNA molecules amplified by NASBA. A fluorescently labeled DNA probe at nanomolar concentration was introduced into the NASBA reaction mixture and hybridizing to a distinct sequence of the amplified RNA molecule. The specific hybridization and extension of this probe during amplification reaction, resulting in an increase of its diffusion time, was monitored online by FCS. As a consequence, after having reached a critical concentration of 0.1-1 nM (threshold for unaided FCS detection), the number of amplified RNA molecules in the further course of reaction could be determined. Evaluation of the hybridization/extension kinetics allowed an estimation of the initial HIV-1 RNA concentration that was present at the beginning of amplification. The value of initial HIV-1 RNA number enables discrimination between positive and false-positive samples (caused for instance by carryover contamination)-this possibility of discrimination is an essential necessity for all diagnostic methods using amplification systems (PCR as well as NASBA). Quantitation of HIV-1 RNA in plasma by combination of NASBA with FCS may also be useful in assessing the efficacy of anti-HIV agents, especially in the early infection stage when standard ELISA antibody tests often display negative results.
基于核酸序列的扩增技术(NASBA)已被证明是一种超灵敏的方法,可用于诊断血浆中的HIV-1,即使在HIV-1原发感染阶段也适用。该技术与荧光相关光谱法(FCS)相结合,能够在线检测由NASBA扩增的HIV-1 RNA分子。将纳摩尔浓度的荧光标记DNA探针引入NASBA反应混合物中,并使其与扩增RNA分子的特定序列杂交。在扩增反应过程中,该探针的特异性杂交和延伸导致其扩散时间增加,通过FCS在线监测这一过程。结果,在达到0.1-1 nM的临界浓度(FCS无辅助检测的阈值)后,可确定反应后续过程中扩增RNA分子的数量。对杂交/延伸动力学的评估可以估算扩增开始时存在的初始HIV-1 RNA浓度。初始HIV-1 RNA数量的值能够区分阳性和假阳性样本(例如由残留污染引起)——这种区分的可能性对于所有使用扩增系统的诊断方法(PCR以及NASBA)来说都是必不可少的。将NASBA与FCS相结合对血浆中的HIV-1 RNA进行定量,在评估抗HIV药物的疗效方面也可能有用,尤其是在早期感染阶段,此时标准ELISA抗体检测通常显示阴性结果。